Heart Test Laboratories (HSCS) Competitors $3.90 -0.59 (-13.14%) Closing price 03:46 PM EasternExtended Trading$4.15 +0.25 (+6.38%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. PETV, NXGL, IRIX, XAIR, NXL, LFWD, VVOS, ICU, BTCY, and PAVMShould you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include PetVivo (PETV), NEXGEL (NXGL), IRIDEX (IRIX), Beyond Air (XAIR), Nexalin Technology (NXL), ReWalk Robotics (LFWD), Vivos Therapeutics (VVOS), SeaStar Medical (ICU), Biotricity (BTCY), and PAVmed (PAVM). These companies are all part of the "medical equipment" industry. Heart Test Laboratories vs. PetVivo NEXGEL IRIDEX Beyond Air Nexalin Technology ReWalk Robotics Vivos Therapeutics SeaStar Medical Biotricity PAVmed PetVivo (NASDAQ:PETV) and Heart Test Laboratories (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, analyst recommendations, risk and dividends. Is PETV or HSCS more profitable? Heart Test Laboratories has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Heart Test Laboratories' return on equity of -117.76% beat PetVivo's return on equity.Company Net Margins Return on Equity Return on Assets PetVivo-902.82% -4,813.07% -281.78% Heart Test Laboratories N/A -117.76%-84.09% Which has more risk & volatility, PETV or HSCS? PetVivo has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, Heart Test Laboratories has a beta of 2.61, suggesting that its stock price is 161% more volatile than the S&P 500. Do institutionals and insiders hold more shares of PETV or HSCS? 24.5% of PetVivo shares are held by institutional investors. Comparatively, 17.2% of Heart Test Laboratories shares are held by institutional investors. 10.8% of PetVivo shares are held by company insiders. Comparatively, 1.8% of Heart Test Laboratories shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts prefer PETV or HSCS? Heart Test Laboratories has a consensus target price of $13.00, indicating a potential upside of 233.33%. Given Heart Test Laboratories' stronger consensus rating and higher possible upside, analysts clearly believe Heart Test Laboratories is more favorable than PetVivo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, PETV or HSCS? Heart Test Laboratories has lower revenue, but higher earnings than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than Heart Test Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPetVivo$1.05M17.05-$10.95M-$0.45-1.64Heart Test Laboratories$14.70K286.80-$6.61M-$7.48-0.52 Does the MarketBeat Community prefer PETV or HSCS? Heart Test Laboratories received 6 more outperform votes than PetVivo when rated by MarketBeat users. CompanyUnderperformOutperformPetVivoN/AN/AHeart Test LaboratoriesOutperform Votes685.71% Underperform Votes114.29% Does the media prefer PETV or HSCS? In the previous week, Heart Test Laboratories had 1 more articles in the media than PetVivo. MarketBeat recorded 1 mentions for Heart Test Laboratories and 0 mentions for PetVivo. PetVivo's average media sentiment score of 0.00 equaled Heart Test Laboratories'average media sentiment score. Company Overall Sentiment PetVivo Neutral Heart Test Laboratories Neutral SummaryHeart Test Laboratories beats PetVivo on 12 of the 16 factors compared between the two stocks. Get Heart Test Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeart Test LaboratoriesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.22M$9.51B$5.35B$8.38BDividend YieldN/A1.61%5.22%4.10%P/E Ratio-0.4920.8726.8419.71Price / Sales286.8063.84391.39116.98Price / CashN/A19.6738.2534.62Price / Book0.355.056.794.50Net Income-$6.61M$284.66M$3.23B$248.18M7 Day Performance16.77%-1.23%4.07%1.14%1 Month Performance21.88%4.43%12.52%15.20%1 Year Performance-30.73%-21.30%16.83%6.56% Heart Test Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeart Test Laboratories2.4046 of 5 stars$3.90-13.1%$13.00+233.3%-23.6%$4.22M$14,700.00-0.4910News CoveragePETVPetVivoN/A$0.75+7.1%N/A+4.1%$18.18M$1.05M-1.6720NXGLNEXGEL0.9182 of 5 stars$2.36-1.3%N/A+1.3%$18.07M$10.23M-4.0710Gap DownIRIXIRIDEX0.8043 of 5 stars$1.07-0.5%N/A-62.2%$17.80M$48.67M-1.58120Analyst ForecastHigh Trading VolumeXAIRBeyond Air3.9761 of 5 stars$0.19+0.2%$1.50+689.1%-85.3%$16.42M$3.02M-0.1870Gap DownNXLNexalin Technology2.7878 of 5 stars$1.22-3.9%$5.00+309.8%+0.0%$16.26M$168,721.00-1.913LFWDReWalk Robotics2.82 of 5 stars$1.26-2.7%$9.00+617.1%-74.8%$13.29M$25.66M-0.5060Earnings ReportVVOSVivos Therapeutics1.4377 of 5 stars$2.19-5.4%$6.10+179.2%-4.5%$12.61M$15.03M-0.38160Earnings ReportICUSeaStar Medical1.1202 of 5 stars$1.25-0.8%N/A-87.4%$12.45M$135,000.00-0.112Earnings ReportBTCYBiotricityN/A$0.49+5.4%N/A-53.9%$12.08M$12.06M-0.4540Gap UpPAVMPAVmed4.0874 of 5 stars$0.63-0.8%$19.50+3,020.0%-65.6%$10.68M$3.00M-0.1490 Related Companies and Tools Related Companies PetVivo Competitors NEXGEL Competitors IRIDEX Competitors Beyond Air Competitors Nexalin Technology Competitors ReWalk Robotics Competitors Vivos Therapeutics Competitors SeaStar Medical Competitors Biotricity Competitors PAVmed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HSCS Stock Free HSCS Stock Alerts